Looking Deep Into the Heterogeneity of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Can We Understand It Better?

J Clin Oncol. 2016 Feb 20;34(6):521-3. doi: 10.1200/JCO.2015.64.7495. Epub 2016 Jan 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy*
  • Carcinoma / chemistry*
  • Carcinoma / drug therapy*
  • Female
  • Gene Expression*
  • Humans
  • Receptor, ErbB-2 / antagonists & inhibitors*

Substances

  • Receptor, ErbB-2